We therefore selected a subset of proteins with no known previous association with DMD (Pgam1, Tnni3, Camk2b, Capn1 and Adamts5) and Cycs (which showed a strong response to therapy) for validation by ELISA (Fig. 3). This evidence concerns the gene CAMK2B and Duchenne muscular dystrophy.